Skip to main content
ECAT
NYSE Unknown

Glass Lewis Recommends Voting for ECAT's Board Nominees, Rejects Activist Slate

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
9
Price
$15.23
Mkt Cap
0
52W Low
$13.36
52W High
$17.14
Market data snapshot near publication time

summarizeSummary

BlackRock ESG Capital Allocation Term Trust announced that Glass Lewis, a key proxy advisory firm, recommended shareholders vote for the incumbent board nominees and against activist investor Saba Capital Management's slate, a significant development in the ongoing proxy battle.


check_boxKey Events

  • Glass Lewis Endorses Incumbent Board

    Leading independent proxy advisory firm Glass Lewis recommended shareholders vote on the WHITE proxy card FOR all nine of BlackRock ESG Capital Allocation Term Trust's incumbent board nominees.

  • Activist Nominees Rejected

    Glass Lewis explicitly rejected the full slate of nominees proposed by activist investor Saba Capital Management.

  • Saba Capital's Reduced Stake Noted

    Glass Lewis highlighted that Saba Capital Management has sold down nearly a third of its stake in the Fund, potentially weakening its influence in the proxy contest.

  • Annual Meeting Scheduled

    The annual meeting where shareholders will vote on the board nominees is scheduled for June 9, 2026.


auto_awesomeAnalysis

This filing is a critical development in the ongoing proxy battle between BlackRock ESG Capital Allocation Term Trust (ECAT) and activist investor Saba Capital Management. Glass Lewis, a leading independent proxy advisory firm, carries significant weight with institutional investors. Their recommendation to vote for the incumbent board and against Saba's nominees provides a strong endorsement for current management and could decisively sway the outcome of the June 9th annual meeting. The additional detail that Saba has reduced its stake further weakens the activist's position.

At the time of this filing, ECAT was trading at $15.23 on NYSE in the Unknown sector. The 52-week trading range was $13.36 to $17.14. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ECAT - Latest Insights

ECAT
May 21, 2026, 5:00 PM EDT
Filing Type: DEFA14A
Importance Score:
9
ECAT
May 13, 2026, 4:23 PM EDT
Filing Type: DEFA14A
Importance Score:
8
ECAT
May 12, 2026, 4:29 PM EDT
Filing Type: DEFA14A
Importance Score:
8
ECAT
May 11, 2026, 5:27 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
ECAT
May 07, 2026, 10:02 AM EDT
Filing Type: DFAN14A
Importance Score:
8
ECAT
Apr 27, 2026, 6:00 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
ECAT
Apr 14, 2026, 4:40 PM EDT
Filing Type: DEFA14A
Importance Score:
8
ECAT
Apr 03, 2026, 1:22 PM EDT
Filing Type: DEFC14A
Importance Score:
9
ECAT
Apr 02, 2026, 4:17 PM EDT
Filing Type: DEFA14A
Importance Score:
8
ECAT
Mar 31, 2026, 4:27 PM EDT
Filing Type: DEFA14A
Importance Score:
8